Novartis AG
NVSNYSEPharmaceutical PreparationsFiscal year ends December 31Also trades as NVSEF
$161.52+0.73 (+0.45%)
Close on Nov 2, 2026Market cap $308.20BP/E 22.6Yield –
Novartis Total Misconduct Allegations by Year
Novartis Total Misconduct Allegations: 1,116 in FY2025, down 39.1% from a year earlier.
Latest, FY2025
1,116
Period ended Dec 31, 2025
Change on a year earlier
-39.1%
1,834 in FY2024
History
2 years
Since FY2024
Sources
1
Novartis Official IR / Sustainability Report — novartis-esg-data-summary-2025.pdf
Where the FY2025 figure comes from
“| Total allegations | 1 116 | 1 834 | ∆ | 38 |”
Source: Novartis Official IR / Sustainability Report — novartis-esg-data-summary-2025.pdf ↗
Reported in ESG Data Summary 2025.
Annual history
Hover a value to see the sentence it was read from; calculated values show their formula
| Period | Ended | Total Misconduct Allegations | Year on year | Source |
|---|---|---|---|---|
| FY2025 | Dec 31, 2025 | 1,116 | -39.1% | Novartis Official IR / Sustainability Report — novartis-esg-data-summary-2025.pdf ↗ |
| FY2024 | Dec 31, 2024 | 1,834 | – | Novartis Official IR / Sustainability Report — novartis-esg-data-summary-2025.pdf ↗ |
Breakdown
What makes up total Misconduct Allegations
- Substantiated Cases745 · FY2025
- Employees Dismissed or Resigned Due to Serious Misconduct81 · FY2025
- Percentage of Employees Completing Code of Conduct Training & Certification (%)98.0% · FY2025
- US Policy Lobbying Expenditures (USD millions)5.17 · FY2025
- EU Policy Lobbying Expenditures (USD millions)3.08 · FY2025
- Total Global Legal Political Contributions (USD millions)1.68 · FY2025
Cite this data
StockData. (2026). Novartis Total Misconduct Allegations, annual FY2024–FY2025 [Data set]. Compiled from Novartis SEC filings and investor materials. https://stockdatahq.com/stocks/nvs/kpis/gov-allegations-total
See every metric in the Novartis KPI table. Data updated Nov 2, 2026.